Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC
Clinical trial NCT03181308 · COMPLETED
Trial details
- NCT number
- NCT03181308
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-09
- Primary completion
- 2019-07-22
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.